Antibacterial activity of a bacteriocin from Lactobacillus paracasei HL32 against Porphyromonas gingivalis

Archives of Oral Biology

Volumn 51, Issue 9, 2006, Pages 784-793

  Pangsomboon, Kanokporn ^a   Kaewnopparat, Sanae ^a   Pitakpornpreecha, Thanawat ^a   Srichana, Teerapol ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Lactobacillus paracasei; Periodontal diseases; Porphyromonas gingivalis; Purification

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIOCIN;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL INFECTION; BACTEROIDACEAE INFECTION; CELL WALL; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; GENETICS; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MOLECULAR WEIGHT; PERIODONTITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PORPHYROMONAS GINGIVALIS; SCANNING ELECTRON MICROSCOPY; THIN LAYER CHROMATOGRAPHY; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOCINS; BACTEROIDACEAE INFECTIONS; CELL WALL; CHROMATOGRAPHY, THIN LAYER; ELECTROPHORESIS, POLYACRYLAMIDE GEL; LACTOBACILLUS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

LACTOBACILLUS; LACTOBACILLUS PARACASEI; PORPHYROMONAS GINGIVALIS;

EID: 33747447722     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2006.03.008     Document Type: Article

References (33)

1. Klaenhammer T.R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12 (1993) 39-85
2. Kaewnopparat S. Human Lactobacilli as Antidiarrheal and Anticholesterol Bio-agents: In Vitro and In Vivo Studies. PhD Thesis. Bangkok: Faculty of Graduate Studies, Mahidol University; 1999.
3. Huttunen E., Noro K., and Yang Z. Purification and identification of antimicrobial substances produced by two Lactobacillus casei strains. Int Diary J 5 (1987) 503-513
4. Kabuki T., Saito T., Kawai Y., Uemura J., and Itoh T. Production, purification and characterization of reutericin 6, a bacteriocin with lytic activity produced by Lactobacillus reuteri LA6. Int J Food Microbiol 34 (1997) 145-156
5. Onda T., Yanagida F., Tsuji M., Shinohara T., and Yokotsuka K. Production and purification of bacteriocin peptide produced by Lactobacillus sp. strain GM005, isolated from Miso-paste. Int J Food Microbiol 87 (2003) 153-159
6. Kaewsrichan J., Douglas C.W., Nissen-Meyers J., Fimland G., and Teanpaisan R. Characterization of a bacteriocin produced by Prevotella nigrescens ATCC 25261. Lett Appl Microbiol 39 (2004) 451-458
7. Boman H.G. Antibacterial peptides: key components needed in immunity. Cell 65 (1991) 205-207
8. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
9. Ryadnov M.G., Degtyareva O.V., Kashparov I.V., and Mitin Y.U. A new synthetic all-D-peptide with high bacterial and low mammalian cytotoxicity. Peptides 2 (2002) 1869-1871
10. Kinane D.F. Causation and pathogenesis of periodontal disease. Periodontol 2000 25 (2001) 8-20
11. Southard G.L., and Godowski K.C. Subgingival controlled release of antimicrobial agents in the treatment of periodontal disease. Int J Antimicrob Ag 9 (1998) 239-253
12. Collins J.G., Windley III H.W., Arnold R.R., and Offenbacher S. Effects of a Porphyromonas gingivalis infection on inflammatory mediator response and pregnancy outcome in hamster. Infect Immun 62 (1994) 4356-4361
13. Kang I.C., and Kuramitsu H.K. Induction of monocyte hemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunol Med Mic 34 (2002) 311-317
14. Lamont R.J., and Yilmaz O. In or out: the invasiveness of oral bacteria. Peridontol 2000 30 (2002) 61-69
15. Masuda K., Tomita K., Hayashi H., Yoshioka M., Hinode D., and Nakamura R. Consumption of peptide-derivatised arginine by a periodontopathogenic bacterium, Porphyromonas gingivalis. Anaerobe 7 (2001) 209-217
16. Bhatti M., Nair S.P., MacRobert A.J., et al. Identification of photolabile outer membrane proteins of Porphyromonas ginigivalis. Curr Microbiol 43 (2001) 96-99
17. Slots J. Clinical note. Selection of antimicrobial agents in periodontal therapy. J Periodontal Res 37 (2002) 389-398
18. Edward D.I. Antibiotic and chemotherapy. In: Finch G., Greenwood D., Norrby S.R., and Whiteley R.J. (Eds). Anti-infective agents and their use in therapy (2001), Churchill Livingstone, Cornwall 335-336
19. Loesche W.J., Schmidt E., Smith B.A., Morrison E.C., Caffesse R., and Hujoel P.P. Effects of metronidazole on periodontal treatment needs. J Periodontol 62 (1991) 247-257
20. Chan Y., and Chan C.H. Antibiotic resistance of pathogenic bacteria from odontogenic infections in Taiwan. J Microbiol Immunol Infect 36 (2003) 105-110
21. Sanai Y., Persson G.R., Starr J.R., et al. Presence and antibiotic resistance of Porphyromanas gingivalis, Prevotella intermedia, and Prevotella nigrescens in children. J Clin Periodontol 29 (2002) 929-934
22. Walker C.B. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 10 (1996) 79-88
23. Grenier D. Antagonistic effect of oral bacteria towards Treponema denticola. J Clin Microbiol 34 (1996) 1249-1252
24. Almstahl A., Wikstrom M., and Kroneld U. Microflora in oral ecosystems in Sjörgren's syndrome. J Rheumatol 28 (2001) 1007-1013
25. Koo H., Gomes B.P.F.A., Rosalen P.L., Ambrosano G.M.B., Park Y.K., and Cury J.A. In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. Arch Oral Biol 45 (2000) 141-148
26. Javadpour M.M., Juban M.M., Lo W.C., et al. De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem 39 (1996) 3107-3113
27. Liu H.J., Chang B.Y., Yan H.W., Yu F.H., and Liu X.X. Determination of amino acids in food and feed by derivatization with 6-aminoquionolyl-n-hydroxysuccinimidyl carbamate and reversed-phase liquid chromatographic separation. J AOAC Int 78 (1995) 736-744
28. Wade W.G., and Addy M. Comparison of in vitro activity of niridazole, metronidazole and tetracycline against subgingival bacteria in chronic periodontitis. J Appl Bacteriol 63 (1987) 455-457
29. Andrés M.T., Chung W.O., Roberts M.C., and Fierro J.F. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother 42 (1998) 3022-3023
30. Piard J.C., Muriana P.M., Desmazeaud M.J., and Klaenhammer T.R. Purification and partial characterization of lacticin 481, a lanthionine-containing bacteriocin produced by Lactococcus lactis subsp. lactis CNRZ 481. Appl Environ Microbiol 58 (1992) 279-284
31. Huot E., Meghrous J., Barrena-Gonzalea C., and Petitdemange H. Bacteriocin J46, a new bacteriocin produced by Lactococcus lactis subsp. cremoris J46: isolation and characterization of the protein and its gene. Anaerobe 2 (1996) 137-145
32. Kondejewski L.H., Farmer S.W., Wishart D.S., Farmer S.W., Kay C.M., and Hancock R.E.W. Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidins analogs. Biol Chem 271 (1996) 25261-25268
33. Takashiba S., Myokai F., Ohyama H., et al. Concepts for the biological treatment of periodontal diseases. In: Bartold P.M., Ishikawa I., and Sirirat M. (Eds). Progress of periodontal research and practice in Asian pacific countries (2000), Asian Pacific Society of Periodontology, Brisbane 42-52